InvestorsHub Logo
Followers 68
Posts 2662
Boards Moderated 0
Alias Born 09/21/2016

Re: None

Sunday, 02/25/2018 10:00:36 PM

Sunday, February 25, 2018 10:00:36 PM

Post# of 144813
Response from IR

We concur.

A press release was set to be published before the information about the Phase 2b trial was submitted to the SEC.  Through an unexpected glitch, that didn’t occur.

We will endeavor to correct the situation at the earliest opportunity.

Thank you for your continued support of PharmaCyte.

Investor Relations
23046 Avenida de la Carlota, Suite 600
Laguna Hills, California 92653
O 917.595.2850 | F 917.595.2851 | M 917.595.2856

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PMCB News